GammaTile news

Intracranial brachytherapy has become an increasingly prominent part of the neurosurgical oncologist’s toolbox. In this episode, we will explore some of the indications, active areas of exploration, and current controversies surrounding its use. 

Guest faculty: Wenya Linda Bi and Phillip Devlin
Co-hosts: W. Christopher Newman and Seth Oliveria

This episode of the ACRO Podcast is sponsored by GT Medical Technologies:

In the latest episode of the ACRO Podcast, our host ACRO President-elect Brian Lally, MD speaks with Tugce Kutuk, MD, a radiation oncology resident at Ohio State University about GammaTile® Brachytherapy. GammaTile® is surgically targeted radiation therapy that has been FDA-cleared for treating operable brain tumors. 

Dr. Jay McCracken and The Game on Glio Podcast join Hope Rises for this Daytime Buffalo segment to talk about their innovative and lifesaving work for those fighting brain cancer, as well as critical advocacy efforts. In honor of Brain Cancer Awareness Month in May, there is hope in the form of treatments like GammaTile.

D. Jay McCracken, MD, FAANS, is a Neurosurgical Oncologist and the Medical Director of the Stereotactic Radiosurgery Program at Piedmont Hospital in Atlanta, GA.

With GammaTile, we can do an excellent job of delivering a very high dose of radiation specifically to the problem areas while sparing healthy brain tissue that is only millimeters away.” – Imran Mohiuddin, MD, PhD, Radiation Oncologist, AdventHealth Orlando.

GammaTile is the first and only tile-based radiation therapy for the treatment of operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was recently named as Florida’s first GammaTile Center of Excellence.

Dr. D. Jay McCracken, Neurosurgeon and Medical Director of the Stereotactic Radiosurgery Program at Piedmont Atlanta Hospital, is featured in this news segment, explaining how GammaTile radiation therapy can help patients with operable brain tumors.

Ascension St. Vincent's Riverside has successfully treated its first patient with GammaTile® Therapy—a major step forward in the fight against brain tumors.

“GammaTile is a game changer in surgical care for our patients with brain tumors,” said Dr. Aristotelis Filippidis, Neurosurgeon at St. Vincent's. “The highly targeted therapy at the tumor cavity after resection, the area that is needed most to delay recurrence, is delivered while patients go about their everyday lives, reducing their hardship after surgery.”